Transition Therapeutics Inc. Announces Participation in 12th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

TORONTO, Feb. 5, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. (“Transition” or the “Company”) (Nasdaq:TTHI) (TSX:TTH) today announced that Dr. Tony Cruz, Chairman and Chief Executive Officer, will participate on a panel entitled “Alzheimer’s Disease: A Panel to Remember,” at the upcoming 12th Annual BIO CEO & Investor Conference on Tuesday, February 9th, 2010 at 9:00am (Eastern time) at the Waldorf Astoria in New York.

MORE ON THIS TOPIC